Work

Randomized phase II trial of weekly paclitaxel, carboplatin, cetuximab (PCC) versus cetuximab, docetaxel, cisplatin, and fluorouracil (C-TPF) in previously untreated patients with locally advanced head and neck squamous cell carcinoma.

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.15_suppl.tps6102

Authors: Erminia Massarelli, Robert I. Haddad, J. Jack Lee, Adam S. Garden, George R. Blumenschein, William N. William, Roy B. Tishler, Bonnie S. Glisson, Kathryn A. Gold, Faye M. Johnson, Lawrence E. Ginsberg, Michelle D. Williams, Jeffrey Myers, Merrill S. Kies, Vassiliki Papadimitrakopoulou

Institutions: The University of Texas MD Anderson Cancer Center, Harvard University, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Dana-Farber Brigham Cancer Center

Language: English

Topic: Head and Neck Cancer Studies

Subfield: Otorhinolaryngology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2736139470

Cites:

Cited by: 3

Related to: 10